Year |
Citation |
Score |
2010 |
Rauen KA, Schoyer L, McCormick F, Lin AE, Allanson JE, Stevenson DA, Gripp KW, Neri G, Carey JC, Legius E, Tartaglia M, Schubbert S, Roberts AE, Gelb BD, Shannon K, et al. Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. American Journal of Medical Genetics. Part A. 152: 4-24. PMID 20014119 DOI: 10.1002/Ajmg.A.33183 |
0.619 |
|
2009 |
Søvik O, Schubbert S, Houge G, Steine SJ, Norgård G, Engelsen B, Njølstad PR, Shannon K, Molven A. De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features. Bmj Case Reports. 2009. PMID 21686750 DOI: 10.1136/Bcr.07.2008.0550 |
0.724 |
|
2008 |
Denayer E, Parret A, Chmara M, Schubbert S, Vogels A, Devriendt K, Frijns JP, Rybin V, de Ravel TJ, Shannon K, Cools J, Scheffzek K, Legius E. Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation. Human Mutation. 29: 232-9. PMID 17979197 DOI: 10.1002/Humu.20616 |
0.693 |
|
2007 |
Schubbert S, Bollag G, Lyubynska N, Nguyen H, Kratz CP, Zenker M, Niemeyer CM, Molven A, Shannon K. Biochemical and functional characterization of germ line KRAS mutations. Molecular and Cellular Biology. 27: 7765-70. PMID 17875937 DOI: 10.1128/Mcb.00965-07 |
0.723 |
|
2007 |
Søvik O, Schubbert S, Houge G, Steine SJ, Norgård G, Engelsen B, Njølstad PR, Shannon K, Molven A. De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features. Journal of Medical Genetics. 44: e84. PMID 17601930 DOI: 10.1136/Jmg.2007.049361 |
0.721 |
|
2007 |
Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer Nature Reviews Cancer. 7: 295-308. PMID 17384584 DOI: 10.1038/Nrc2109 |
0.701 |
|
2007 |
Schubbert S, Bollag G, Shannon K. Deregulated Ras signaling in developmental disorders: new tricks for an old dog Current Opinion in Genetics and Development. 17: 15-22. PMID 17208427 DOI: 10.1016/J.Gde.2006.12.004 |
0.723 |
|
2007 |
Schubbert S, Shannon K, Bollag G. Erratum: Hyperactive Ras in developmental disorders and cancer Nature Reviews Cancer. 7: 564-564. DOI: 10.1038/Nrc2175 |
0.535 |
|
2006 |
Kratz CP, Schubbert S, Bollag G, Niemeyer CM, Shannon KM, Zenker M. Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders. Cell Cycle (Georgetown, Tex.). 5: 1607-11. PMID 16921267 DOI: 10.4161/Cc.5.15.3128 |
0.747 |
|
2006 |
Schubbert S, Zenker M, Rowe SL, Böll S, Klein C, Bollag G, van der Burgt I, Musante L, Kalscheuer V, Wehner LE, Nguyen H, West B, Zhang KY, Sistermans E, Rauch A, et al. Germline KRAS mutations cause Noonan syndrome. Nature Genetics. 38: 331-6. PMID 16474405 DOI: 10.1038/Ng1748 |
0.73 |
|
2006 |
Schubbert S, Sovik O, Bollag G, Nguyen H, Rowe SL, Kratz C, Zenker MM, Niemeyer CM, Molven A, Shannon K. Biochemical and Functional Analysis of Germline KRAS Mutations That Cause Disorders of the Noonan Syndrome Spectrum. Blood. 108: 1431-1431. DOI: 10.1182/Blood.V108.11.1431.1431 |
0.692 |
|
2006 |
Schubbert S, Zenker M, Rowe SL, Böll S, Klein C, Bollag G, Burgt Ivd, Musante L, Kalscheuer V, Wehner L, Nguyen H, West B, Zhang KYJ, Sistermans E, Rauch A, et al. Corrigendum: Germline KRAS mutations cause Noonan syndrome Nature Genetics. 38: 598. DOI: 10.1038/Ng0506-598 |
0.655 |
|
2005 |
Schubbert S, Lieuw K, Rowe SL, Lee CM, Li X, Loh ML, Clapp DW, Shannon KM. Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood. 106: 311-7. PMID 15761018 DOI: 10.1182/Blood-2004-11-4207 |
0.701 |
|
2005 |
Schubbert S, Zenker M, Rowe SL, Böll S, Klein C, Burgt Ivd, Musante L, Nguyen H, West B, Bollag G, Niemeyer CM, Shannon KM, Kratz CP. Novel Germ Line Mutations in the KRAS2 Gene Cause Noonan Syndrome and Deregulate Hematopoietic Cell Growth. Blood. 106: 1602-1602. DOI: 10.1182/Blood.V106.11.1602.1602 |
0.739 |
|
2004 |
Loh ML, Vattikuti S, Schubbert S, Reynolds MG, Carlson E, Lieuw KH, Cheng JW, Lee CM, Stokoe D, Bonifas JM, Curtiss NP, Gotlib J, Meshinchi S, Le Beau MM, Emanuel PD, et al. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood. 103: 2325-31. PMID 14644997 DOI: 10.1182/Blood-2003-09-3287 |
0.732 |
|
Show low-probability matches. |